Paramdeep Baweja, MD
NPI 1447413331 · Cardiovascular Disease Physician · Kansas City, MO
Enrolled with Medicare as Practitioner - Cardiovascular Disease (cardiology) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1447413331
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 2009003004 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
17 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,106 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report Only93010 | 566 | $8 |
| Ultrasound of Heart With Color-Depicted Blood Flow, Rate, Direction and Valve Function93306 | 143 | $65 |
| Heart Muscle Strain Imaging93356 | 122 | $11 |
| Nuclear Medicine Studies of Heart Muscle at Rest and With Stress and Spect78452 | 37 | $70 |
| Exercise Or Drug-Induced Heart Stress Test With Electrocardiogram (ecg) With Review By Physician93018 | 37 | $13 |
| Exercise Or Drug-Induced Heart Stress Test With Electrocardiogram (ecg) With Supervision By Physician |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Ticagrelorbrand: Brilinta | 34 |
| Sacubitril/Valsartanbrand: Entresto | 16 |
| Spironolactone | 13 |
| Apixabanbrand: Eliquis | 11 |
| Isosorbide Mononitratebrand: Isosorbide Mononitrate Er | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-07-09
- Last updated
- 2020-09-09
- Certified
- 2020-09-09
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.